OasisLMS

E. Danielle Dean, PhD

Assistant Professor of Medicine and Molecular Physiology and Biophysics 

Vanderbilt University Medical Center 

Nashville, TN 

Dr. Danielle Dean is an Assistant Professor of Medicine and Molecular Physiology and Biophysics at Vanderbilt University School of Medicine. She is also the Chair of the ADA's Islet BIology Interest Group. Her research is focused on understanding how individual islet endocrine cells metabolize nutrients to coordinated hormone secretion and

Holger Russ, PhD 

Associate Professor 

UF Diabetes Institute 

Department of Pharmacology & Therapeutics at the University of Florida College of Medicine 

Gainesville, FL 

Kimber Simmons, MD, MS 

Associate Professor of Pediatrics 

Barbara Davis Center for Diabetes  

University of Colorado School of Medicine 

Aurora, CO 

Dr. Simmons directs the Barbara Davis Center’s Early Type 1 Diabetes and Immunotherapy Program, implementing teplizumab in clinical practice and providing care for individuals in early T1D. She leads Ask the EXPERTS, a national program guiding providers and families in interpreting and managing screening results. As principal investigator for multiple prevention and new-onset trials, her research focuses on advancing immunotherapies to preserve β-cell function and ultimately prevent type 1 diabetes. 

Michael R. Rickels, MD., MS 

Professor of Medicine 

University of Pennsylvania Perelman School of Medicine 

Philadelphia, PA 

Dr. Rickels is the Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases at the University of Pennsylvania Perelman School of Medicine where Dr. Rickels serves as Director of Clinical Science in the Division of Endocrinology, Diabetes and Metabolism, Director for Translational Research in the Institute for Diabetes, Obesity & Metabolism, and Medical Director for the Pancreatic Islet Cell Transplant Program. Dr. Rickels conducts patient‐oriented diabetes research that is focused on the physiology of islet function and replacement and glucose counterregulation in defense against hypoglycemia in type 1 diabetes and pancreatogenic forms of diabetes such as cystic fibrosis‐related diabetes. This work has been continuously funded by the National Institutes of Health. Dr. Rickels is an elected member of the Association of American Physicians and presently serves as Treasurer for the International Pancreas and Islet Transplant Association, and as Associate Editor for the American Diabetes Association’s clinical research journal Diabetes Care, where he co‐hosts the podcast Diabetes Care “On Air”.